주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
Updated : Friday, March 29, 2024, 15:00
Home
Login
Sign in
한국어
National
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
Macro-Economics
Trade
Foreign Exchanges
Industries
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
Company & Stock Tracking
Market Trend & Outlook
Finance
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
Science
New Tech
Blockchain
ESG
Environment
Social
Governance
Event
Exhibitions
Conferences
People
K-Culture
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
Editorials
Contributions
Who's Who
기사검색
검색
All articles
List
Subject Type
Summary Type
Photo Type
Korean-style Open Innovation Gains Traction as Domestic, Foreign Pharmaceutical Companies Team Up
Jasmine Choi
2023.07.31 08:33
Samsung Bioepis, Humira Biosimilar Listed by US PBM Prime
Jasmine Choi
2023.07.14 10:42
Yuhan Corp.: Expect Leclaza-Rybrevant Concomitant Data This Year
Kim Tae-hee
2023.02.24 09:15
Samsung Biologics Can Process 30% of Global CDMO Production
Choi Mun -hee
2022.10.12 13:23
Yuhan Corp.: 1Q22 Review: Plenty More Than Lazertinib
Kim Tae-hee
2022.05.02 13:32
Samsung Biologics to Build Plants in the U.S. and Europe
Choi Moon-hee
2022.03.22 17:12
Yuhan Corp.: Focus More on R&D Than Earnings Momentum
Kim Tae-hee
2022.02.28 16:56
Yuhan: Domestic Sales and Licensing Fees Disappoint
Park Pyeong-kuk
2022.02.17 11:28
European Medicines Agency Resumes Production Site Inspections
Choi Moon-hee
2021.11.23 11:07
Yuhan: Main Business Recovering, Starting with Domestic Leclaza
Park Pyeong-kuk
2021.07.30 14:05
Yuhan: Two Key Issues for Lazertinib
Yoon Young-sil
2021.03.18 10:43
Finance
Yuhan Co.: 4Q19 Review: Earnings Miss Consensus on Deferred Booking of Licensing Income
William Ku
2020.02.28 11:57
처음
1
2
다음
다음
끝
위로
모바일버전
All articles
National
전체
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
전체
Macro-Economics
Trade
Foreign Exchanges
Industries
전체
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
전체
Company & Stock Tracking
Market Trend & Outlook
Finance
전체
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
전체
Science
New Tech
Blockchain
ESG
전체
Environment
Social
Governance
Event
전체
Exhibitions
Conferences
People
K-Culture
전체
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
전체
Editorials
Contributions
Who's Who
전체메뉴닫기